[8-K] Aveanna Healthcare Holdings Inc. Reports Material Event
On 8 Aug 2025 Aveanna Healthcare Holdings Inc. (AVAH) filed a Form 8-K under Item 7.01 (Regulation FD) to furnish an updated investor presentation (Exhibit 99.1). The deck is available in the “Investors” section of the company’s website and via IR e-mail alerts. Because the material is classified as “furnished,” it is not subject to Section 18 liability and will only be incorporated into other SEC filings if specifically referenced. Aveanna reiterates that its website is a primary channel for time-critical disclosures.
- No financial statements, earnings metrics or major transactions accompany this report.
- The 8-K is informational only and has no immediate accounting or voting impact.
Il 8 agosto 2025, Aveanna Healthcare Holdings Inc. (AVAH) ha presentato un modulo 8-K ai sensi della voce 7.01 (Regolamento FD) per fornire una presentazione aggiornata per gli investitori (Allegato 99.1). La presentazione è disponibile nella sezione “Investitori” del sito web della società e tramite avvisi e-mail IR. Poiché il materiale è classificato come “fornito”, non è soggetto alla responsabilità ai sensi della Sezione 18 e sarà incorporato in altri documenti SEC solo se specificamente citato. Aveanna ribadisce che il suo sito web rappresenta un canale principale per le comunicazioni urgenti.
- Non sono allegati a questo rapporto bilanci finanziari, indicatori di utili o operazioni rilevanti.
- Il modulo 8-K ha solo scopo informativo e non ha effetti contabili o di voto immediati.
El 8 de agosto de 2025, Aveanna Healthcare Holdings Inc. (AVAH) presentó un Formulario 8-K bajo el punto 7.01 (Regulación FD) para proporcionar una presentación actualizada para inversores (Exhibición 99.1). La presentación está disponible en la sección “Inversores” del sitio web de la compañía y a través de alertas por correo electrónico de IR. Debido a que el material está clasificado como “proporcionado”, no está sujeto a responsabilidad según la Sección 18 y solo se incorporará en otros documentos de la SEC si se hace referencia específica. Aveanna reitera que su sitio web es un canal principal para divulgaciones críticas en tiempo.
- No se acompañan estados financieros, métricas de ganancias ni transacciones importantes en este informe.
- El 8-K es solo informativo y no tiene impacto contable o de voto inmediato.
2025년 8월 8일, Aveanna Healthcare Holdings Inc.(AVAH)는 규정 FD의 항목 7.01에 따라 업데이트된 투자자 프레젠테이션(첨부문서 99.1)을 제공하기 위해 Form 8-K를 제출했습니다. 이 자료는 회사 웹사이트의 “투자자” 섹션과 IR 이메일 알림을 통해 이용 가능합니다. 자료가 “제공됨”으로 분류되어 섹션 18 책임 대상이 아니며, 특별히 참조되는 경우에만 다른 SEC 제출 문서에 포함됩니다. Aveanna는 웹사이트가 시기적절한 공시를 위한 주요 채널임을 다시 한번 강조합니다.
- 본 보고서에는 재무제표, 수익 지표 또는 주요 거래가 포함되어 있지 않습니다.
- 8-K는 정보 제공용이며 즉각적인 회계 또는 의결 영향이 없습니다.
Le 8 août 2025, Aveanna Healthcare Holdings Inc. (AVAH) a déposé un formulaire 8-K sous l’item 7.01 (Règlement FD) pour fournir une présentation mise à jour pour les investisseurs (Exhibit 99.1). Cette présentation est disponible dans la section « Investisseurs » du site internet de la société et via des alertes e-mail IR. Étant donné que le document est classé comme « fourni », il n’est pas soumis à la responsabilité en vertu de la Section 18 et ne sera intégré dans d’autres dépôts auprès de la SEC que s’il est explicitement référencé. Aveanna rappelle que son site web est un canal principal pour les divulgations sensibles au facteur temps.
- Ce rapport n’est accompagné d’aucun état financier, indicateurs de résultats ou transaction majeure.
- Le 8-K est uniquement informatif et n’a pas d’impact comptable ou de vote immédiat.
Am 8. August 2025 reichte Aveanna Healthcare Holdings Inc. (AVAH) ein Formular 8-K unter Punkt 7.01 (Regulation FD) ein, um eine aktualisierte Investorenpräsentation (Anlage 99.1) bereitstellen. Die Präsentation ist im Bereich „Investoren“ auf der Website des Unternehmens sowie über IR-E-Mail-Benachrichtigungen verfügbar. Da das Material als „bereitgestellt“ klassifiziert ist, unterliegt es nicht der Haftung gemäß Abschnitt 18 und wird nur in andere SEC-Einreichungen aufgenommen, wenn es ausdrücklich referenziert wird. Aveanna bekräftigt, dass seine Website ein primärer Kanal für zeitkritische Offenlegungen ist.
- Dieser Bericht enthält keine Finanzberichte, Gewinnkennzahlen oder wesentliche Transaktionen.
- Das 8-K dient nur zu Informationszwecken und hat keine unmittelbaren buchhalterischen oder stimmberechtigten Auswirkungen.
- None.
- None.
Insights
TL;DR: Routine 8-K; AVAH posts investor deck, no new financial data—neutral impact.
This filing merely alerts investors to an updated presentation and underscores management’s use of its website for real-time disclosures. No quantitative results, guidance, capital raises or strategic transactions were revealed. As such, the event does not alter valuation assumptions or risk profile. Investors may review the deck for messaging nuances, but absence of hard metrics suggests minimal market impact. Overall, a standard Regulation FD communication.
Il 8 agosto 2025, Aveanna Healthcare Holdings Inc. (AVAH) ha presentato un modulo 8-K ai sensi della voce 7.01 (Regolamento FD) per fornire una presentazione aggiornata per gli investitori (Allegato 99.1). La presentazione è disponibile nella sezione “Investitori” del sito web della società e tramite avvisi e-mail IR. Poiché il materiale è classificato come “fornito”, non è soggetto alla responsabilità ai sensi della Sezione 18 e sarà incorporato in altri documenti SEC solo se specificamente citato. Aveanna ribadisce che il suo sito web rappresenta un canale principale per le comunicazioni urgenti.
- Non sono allegati a questo rapporto bilanci finanziari, indicatori di utili o operazioni rilevanti.
- Il modulo 8-K ha solo scopo informativo e non ha effetti contabili o di voto immediati.
El 8 de agosto de 2025, Aveanna Healthcare Holdings Inc. (AVAH) presentó un Formulario 8-K bajo el punto 7.01 (Regulación FD) para proporcionar una presentación actualizada para inversores (Exhibición 99.1). La presentación está disponible en la sección “Inversores” del sitio web de la compañía y a través de alertas por correo electrónico de IR. Debido a que el material está clasificado como “proporcionado”, no está sujeto a responsabilidad según la Sección 18 y solo se incorporará en otros documentos de la SEC si se hace referencia específica. Aveanna reitera que su sitio web es un canal principal para divulgaciones críticas en tiempo.
- No se acompañan estados financieros, métricas de ganancias ni transacciones importantes en este informe.
- El 8-K es solo informativo y no tiene impacto contable o de voto inmediato.
2025년 8월 8일, Aveanna Healthcare Holdings Inc.(AVAH)는 규정 FD의 항목 7.01에 따라 업데이트된 투자자 프레젠테이션(첨부문서 99.1)을 제공하기 위해 Form 8-K를 제출했습니다. 이 자료는 회사 웹사이트의 “투자자” 섹션과 IR 이메일 알림을 통해 이용 가능합니다. 자료가 “제공됨”으로 분류되어 섹션 18 책임 대상이 아니며, 특별히 참조되는 경우에만 다른 SEC 제출 문서에 포함됩니다. Aveanna는 웹사이트가 시기적절한 공시를 위한 주요 채널임을 다시 한번 강조합니다.
- 본 보고서에는 재무제표, 수익 지표 또는 주요 거래가 포함되어 있지 않습니다.
- 8-K는 정보 제공용이며 즉각적인 회계 또는 의결 영향이 없습니다.
Le 8 août 2025, Aveanna Healthcare Holdings Inc. (AVAH) a déposé un formulaire 8-K sous l’item 7.01 (Règlement FD) pour fournir une présentation mise à jour pour les investisseurs (Exhibit 99.1). Cette présentation est disponible dans la section « Investisseurs » du site internet de la société et via des alertes e-mail IR. Étant donné que le document est classé comme « fourni », il n’est pas soumis à la responsabilité en vertu de la Section 18 et ne sera intégré dans d’autres dépôts auprès de la SEC que s’il est explicitement référencé. Aveanna rappelle que son site web est un canal principal pour les divulgations sensibles au facteur temps.
- Ce rapport n’est accompagné d’aucun état financier, indicateurs de résultats ou transaction majeure.
- Le 8-K est uniquement informatif et n’a pas d’impact comptable ou de vote immédiat.
Am 8. August 2025 reichte Aveanna Healthcare Holdings Inc. (AVAH) ein Formular 8-K unter Punkt 7.01 (Regulation FD) ein, um eine aktualisierte Investorenpräsentation (Anlage 99.1) bereitstellen. Die Präsentation ist im Bereich „Investoren“ auf der Website des Unternehmens sowie über IR-E-Mail-Benachrichtigungen verfügbar. Da das Material als „bereitgestellt“ klassifiziert ist, unterliegt es nicht der Haftung gemäß Abschnitt 18 und wird nur in andere SEC-Einreichungen aufgenommen, wenn es ausdrücklich referenziert wird. Aveanna bekräftigt, dass seine Website ein primärer Kanal für zeitkritische Offenlegungen ist.
- Dieser Bericht enthält keine Finanzberichte, Gewinnkennzahlen oder wesentliche Transaktionen.
- Das 8-K dient nur zu Informationszwecken und hat keine unmittelbaren buchhalterischen oder stimmberechtigten Auswirkungen.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
On August 8, 2025, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our") made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.
Use of our Website and Social Media to Distribute Material Company Information
We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.
The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
99.1 |
|
Aveanna Investor Presentation - August 2025 |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
AVEANNA HEALTHCARE HOLDINGS INC. |
|
|
|
|
Date: |
August 8, 2025 |
By: |
/s/ Matthew Buckhalter |
|
|
|
Matthew Buckhalter |
FAQ
What did Aveanna Healthcare (AVAH) disclose in its 8-K dated August 8, 2025?
Does the 8-K include new financial statements or earnings data for AVAH?
Is the investor presentation considered "filed" or "furnished" with the SEC?
Where can investors access Aveanna’s August 2025 presentation?
What is Aveanna Healthcare’s trading symbol and exchange?
